VHL and BRCA1 are also frequently mutated in cancer, but for other tumour suppressor genes, such as RASSF1A, promoter hypermethylation appears to be the principal mechanism for inactivation (for a review, see [127]). The gene discussed is VHL; the disease is cancer.